Graft-versus-host disease cost-effectiveness of therapy: Difference between revisions
Shyam Patel (talk | contribs) |
Shyam Patel (talk | contribs) |
||
| Line 7: | Line 7: | ||
==Cost-Effectiveness of Therapy== | ==Cost-Effectiveness of Therapy== | ||
[[Corticosteroids]] are the most cost-effective therapy for GvHD. [[Prednisone]] and [[methylprednisolone]] are available at very low cost. If [[corticosteroids]] can be used, these should be given first. Second-line therapies such as alternative | [[Corticosteroids]] are the most cost-effective therapy for GvHD. [[Prednisone]] and [[methylprednisolone]] are available at very low cost. If [[corticosteroids]] can be used, these should be given first. Second-line therapies such as alternative immunosuppressants are significantly more expensive. The most expensive therapies include biologics (such as antibodies) and [[cell-based therapies]] such as [[mesenchymal stem cell]] therapy. | ||
==References== | ==References== | ||
Revision as of 02:08, 5 July 2017
|
Graft-versus-host disease |
|
Differentiating Graft-versus-host disease from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Graft-versus-host disease cost-effectiveness of therapy On the Web |
|
American Roentgen Ray Society Images of Graft-versus-host disease cost-effectiveness of therapy |
|
FDA on Graft-versus-host disease cost-effectiveness of therapy |
|
CDC on Graft-versus-host disease cost-effectiveness of therapy |
|
Graft-versus-host disease cost-effectiveness of therapy in the news |
|
Blogs on Graft-versus-host disease cost-effectiveness of therapy |
|
Risk calculators and risk factors for Graft-versus-host disease cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]
Overview
Cost-effectiveness of therapy focuses on the use of balance of medical expenses and therapeutic efficacy. In the case of GvHD therapy, corticosteroids are the least expensive treatment option, and alternative immunosuppressants or biologics are more expensive.
Cost-Effectiveness of Therapy
Corticosteroids are the most cost-effective therapy for GvHD. Prednisone and methylprednisolone are available at very low cost. If corticosteroids can be used, these should be given first. Second-line therapies such as alternative immunosuppressants are significantly more expensive. The most expensive therapies include biologics (such as antibodies) and cell-based therapies such as mesenchymal stem cell therapy.